+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Erythropoietin"

Erythropoietin (EPO) Global Market Report 2024 - Product Thumbnail Image

Erythropoietin (EPO) Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Erythropoietin Drugs - Global Strategic Business Report - Product Thumbnail Image

Erythropoietin Drugs - Global Strategic Business Report

  • Report
  • May 2024
  • 179 Pages
  • Global
From
From
Erythropoietin Drugs Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Erythropoietin Drugs Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
Late Stage Chronic Kidney Disease Drugs Global Market Report 2024 - Product Thumbnail Image

Late Stage Chronic Kidney Disease Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Renal Anemia - Pipeline Insight, 2024 - Product Thumbnail Image

Renal Anemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Anemia in Chronic Kidney - Pipeline Insight, 2024 - Product Thumbnail Image

Anemia in Chronic Kidney - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Global Chronic Kidney Disease (CKD) Drugs Market 2024-2028 - Product Thumbnail Image

Global Chronic Kidney Disease (CKD) Drugs Market 2024-2028

  • Report
  • November 2023
  • 184 Pages
  • Global
From
From
From
From
From
Global Erythropoietin Stimulating Agents Market 2022-2026 - Product Thumbnail Image

Global Erythropoietin Stimulating Agents Market 2022-2026

  • Report
  • August 2022
  • 120 Pages
  • Global
From
From
Chronic Kidney Disease-Anemia - Epidemiology Forecast to 2029 - Product Thumbnail Image

Chronic Kidney Disease-Anemia - Epidemiology Forecast to 2029

  • Report
  • February 2021
  • 30 Pages
  • Global
From
Loading Indicator

Erythropoietin is a hormone produced by the kidneys and liver that stimulates the production of red blood cells. It is used to treat anemia caused by kidney and liver disorders, such as chronic kidney disease and end-stage renal disease. It is also used to treat anemia caused by chemotherapy and other cancer treatments. Erythropoietin is available in both injectable and oral forms, and is often prescribed in combination with other drugs. Erythropoietin is a widely used drug in the treatment of anemia caused by kidney and liver disorders. It is used to increase the production of red blood cells, which can help improve the patient's quality of life. It is also used to reduce the need for blood transfusions, which can be costly and time-consuming. Several companies are involved in the production and distribution of erythropoietin. These include Amgen, Biogen, Johnson & Johnson, Novartis, Pfizer, and Roche. These companies produce and market erythropoietin under various brand names, such as Epogen, Procrit, and Aranesp. Show Less Read more